REBEL EM is licensed under a
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.
Archive
Rebel Category: REBEL EM
Sub-Dissociative IV vs Nebulized Ketamine to Treat Pain
Background: IV subdissociative ketamine at a dose of 0.1 to 0.3mg/kg is increasingly being used as an opioid sparing option for short-term acute pain relief. Alternatively, nebulized ketamine can be used for this indication and may have a benefit as ...
How Much O2 Is Right in COVID?
Background: Hypoxemic respiratory failure is a frequent complicating feature of severe COVID-19 infection. Early in the pandemic, extensive efforts were made to identify the best approach to oxygenation in this group of patients. Best practices settled on aggressive use of ...
Intubation in Surgical Patients: VL vs DL
Background: Although most intubations are typically successful there is still a portion of patients that may require multiple intubation attempts. Repeated intubation attempts could lead to respiratory and hemodynamic complications. We recently covered the DEVICE trial on REBEL EM which ...